VC
Vivo Capital, LLC
Palo Alto CA · SEC CIK 0001674712
$1.10B2026Q2 reported value
47Positions
52.4%Top 10 weight · largest 8.7%
6 / 6New / sold out
26Q126Q2
Top 10 holdings % of portfolio
2026Q2 top buys estimated at quarter-end value
TENX Added+$33.34M
AVBP Added+$27.66M
ABVX Added+$23.37M
ACHV New+$17.96M
EDIT New+$11.52M
2026Q2 top sells estimated at quarter-end value
ERAS Reduced-$147.00M
Terns Pharmaceut Sold out-$70.35M
TNGX Reduced-$24.23M
PRAX Reduced-$22.69M
MANE Sold out-$18.95M
2026Q2 holdings click a header to sort
Export CSV 🔒| Ticker | Name | Value ▼ | Weight | Shares | Share change | Change | Est. flow | Action |
|---|---|---|---|---|---|---|---|---|
| TRVI | Trevi Therapeutics Inc | $95.02M | 8.68% | 5,094,668 | 0 | 0.0% | — | Unchanged |
| PRAX | Praxis Precision Medicines | $90.77M | 8.29% | 271,116 | -67,779 | -20.0% | -$22.69M | Reduced |
| ERAS | Erasca Inc | $75.61M | 6.90% | 4,127,412 | -8,024,068 | -66.0% | -$147.00M | Reduced |
| AVBP | Arrivent BioPharma Inc | $58.44M | 5.34% | 1,682,097 | 796,181 | 89.9% | $27.66M | Added |
| ABVX | Abivax SA - ADR | $55.29M | 5.05% | 414,899 | 175,360 | 73.2% | $23.37M | Added |
| TNGX | Tango Therapeutics Inc | $43.13M | 3.94% | 1,379,769 | -775,011 | -36.0% | -$24.23M | Reduced |
| CRVS | Corvus Pharmaceuticals Inc | $41.92M | 3.83% | 2,805,816 | 0 | 0.0% | — | Unchanged |
| DRUG | Bright Minds Biosciences Inc | $39.11M | 3.57% | 557,172 | 0 | 0.0% | — | Unchanged |
| SVA | Sinovac Biotech Ltd. | $38.19M | 3.49% | 5,903,000 | 0 | 0.0% | — | Unchanged |
| TENX | Tenax Therapeutics Inc | $36.38M | 3.32% | 2,500,000 | 2,291,667 | 1,100.0% | $33.34M | Added |
| ACRS | Aclaris Therapeutics, Inc. | $35.41M | 3.23% | 6,694,637 | 27,971 | 0.4% | $147,967 | Added |
| DYN | Dyne Therapeutics Inc | $34.59M | 3.16% | 1,557,466 | 0 | 0.0% | — | Unchanged |
| DNTH | Dianthus Therapeutics Inc | $34.51M | 3.15% | 353,998 | 0 | 0.0% | — | Unchanged |
| ANRO | Alto Neuroscience Inc | $31.90M | 2.91% | 1,208,858 | 173,307 | 16.7% | $4.57M | Added |
| DBVT | DBV Technologies SA | $30.25M | 2.76% | 1,844,758 | -822,811 | -30.8% | -$13.49M | Reduced |
| SABS | SAB Biotherapeutics Inc | $28.47M | 2.60% | 7,299,909 | -4,120,091 | -36.1% | -$16.07M | Reduced |
| MLTX | Moonlake Immunotherapeutics | $27.26M | 2.49% | 1,400,000 | 400,000 | 40.0% | $7.79M | Added |
| LBRX | LB Pharmaceuticals Inc | $25.96M | 2.37% | 800,000 | 0 | 0.0% | — | Unchanged |
| NERV | Minerva Neurosciences Inc | $23.99M | 2.19% | 4,322,747 | 0 | 0.0% | — | Unchanged |
| DSGN | Design Therapeutics Inc | $23.34M | 2.13% | 1,612,903 | 0 | 0.0% | — | Unchanged |
| ORIC | Oric Pharmaceuticals Inc | $20.02M | 1.83% | 1,848,786 | 0 | 0.0% | — | Unchanged |
| CAMP | CAMP4 Therapeutics Corporation | $18.56M | 1.69% | 4,246,568 | 0 | 0.0% | — | Unchanged |
| FTH | Faeth Therapeutics Inc | $18.05M | 1.65% | 722,020 | 0 | 0.0% | — | Unchanged |
| ACHV | Achieve Life Sciences Inc. | $17.96M | 1.64% | 2,751,032 | 2,751,032 | — | $17.96M | New |
| CMPX | Compass Therapeutics Inc | $16.99M | 1.55% | 7,757,060 | -1,788,406 | -18.7% | -$3.92M | Reduced |
| — | AN2 Therapeutics Inc | $15.26M | 1.39% | 3,153,640 | 0 | 0.0% | — | Unchanged |
| EDIT | Editas Medicine Inc | $11.52M | 1.05% | 3,555,250 | 3,555,250 | — | $11.52M | New |
| GERN | Geron Corp | $11.10M | 1.01% | 8,671,797 | 0 | 0.0% | — | Unchanged |
| ODTX | Odyssey Therapeutics Inc | $10.76M | 0.98% | 575,000 | 575,000 | — | — | First reported |
| EPRX | Eupraxia Pharmaceuticals Inc | $8.92M | 0.81% | 1,350,000 | 0 | 0.0% | — | Unchanged |
| OKUR | Onkure Therapeutics Inc | $8.79M | 0.80% | 1,927,710 | 0 | 0.0% | — | Unchanged |
| OLMA | Olema Pharmaceuticals Inc | $8.40M | 0.77% | 671,843 | 0 | 0.0% | — | Unchanged |
| MNPR | Monopar Therapeutics Inc | $8.38M | 0.77% | 90,500 | 0 | 0.0% | — | Unchanged |
| AURA | Aura Biosciences Inc | $8.28M | 0.76% | 1,166,667 | 1,166,667 | — | $8.28M | New |
| SRZN | Surrozen Inc | $6.75M | 0.62% | 260,000 | 0 | 0.0% | — | Unchanged |
| ALXO | ALX Oncology Holdings Inc | $6.59M | 0.60% | 3,184,713 | 0 | 0.0% | — | Unchanged |
| — | Satellos Bioscience Inc | $6.33M | 0.58% | 813,666 | 0 | 0.0% | — | Unchanged |
| AVTX | Avalo Therapeutics Inc | $5.08M | 0.46% | 275,000 | 275,000 | — | $5.08M | New |
| — | Pepgen Inc | $4.18M | 0.38% | 2,325,000 | 0 | 0.0% | — | Unchanged |
| — | Valneva SE | $3.99M | 0.36% | 763,199 | 763,199 | — | $3.99M | New |
| — | Sera Prognostics Inc | $3.00M | 0.27% | 1,650,440 | 0 | 0.0% | — | Unchanged |
| — | Unicycive Therapeutics | $2.58M | 0.24% | 550,000 | -1,239,916 | -69.3% | -$5.82M | Reduced |
| — | Instil Bio Inc | $2.25M | 0.21% | 292,743 | 0 | 0.0% | — | Unchanged |
| — | InMed Pharmaceuticals Inc | $1.24M | 0.11% | 798,377 | 798,377 | — | $1.24M | New |
| — | Bolt Biotherapeutics Inc | $278,794 | 0.03% | 72,414 | 0 | 0.0% | — | Unchanged |
| — | Pasithea Therapeutics Corp | $239,904 | 0.02% | 465,471 | -2,684,529 | -85.2% | -$1.38M | Reduced |
| DTIL | Precision Biosciences Inc | $36,746 | 0.00% | 4,675 | 0 | 0.0% | — | Unchanged |
| — | Terns Pharmaceuticals Inc | $0 | 0.00% | 0 | -1,334,418 | -100.0% | -$70.35M | Sold out |
| MANE | Veradermics Inc | $0 | 0.00% | 0 | -300,000 | -100.0% | -$18.95M | Sold out |
| COGT | Cogent Biosciences Inc | $0 | 0.00% | 0 | -422,300 | -100.0% | -$16.25M | Sold out |
| — | Soleno Therapeutics Inc | $0 | 0.00% | 0 | -294,909 | -100.0% | -$9.87M | Sold out |
| VRDN | Viridian Therapeutics Inc | $0 | 0.00% | 0 | -166,288 | -100.0% | -$3.25M | Sold out |
| CMPS | Compass Pathway PLC | $0 | 0.00% | 0 | -200,000 | -100.0% | -$1.11M | Sold out |